The 20 Best HER2 Negative Breast Cancer Doctors Near Me in Brighton, MI

Fluent Spanish. Dr. Stoffel is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Familial Adenomatous Polyposis, Familial Colorectal Cancer, Colorectal Cancer, Colonoscopy, and Endoscopy. Dr. Stoffel is board certified in Gastroenterology.

Kathleen Kemmer is a Hematologist and an Oncologist practicing medicine in Brighton, Michigan. Dr. Kemmer is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, HER-2 Positive Breast Cancer, and Angiosarcoma. Dr. Kemmer is board certified in Medical Oncology.

Michael S. Sabel, MD, FACS is the William W. Coon Collegiate Professor of Surgical Oncology in the Department of Surgery at Michigan Medicine. He completed his undergraduate training at Pennsylvania State University and obtained his medical degree from Temple University School of Medicine in Philadelphia. His general surgery residency was performed at Rush-Presbyterian-St. Lukes Medical Center in Chicago. Dr. Sabel completed an NIH-T32 research fellowship in tumor immunology and a surgical oncology fellowship at Roswell Park Cancer Institute in Buffalo, NY. Dr. Sabel joined the University of Michigan faculty in 2001. He has been listed in Best Doctors in America in Surgical Oncology every year since 2007 and has named as one of the U.S. News and World Report Top Doctors in Surgery since 2011.Clinical Specialization:Dr. Sabels clinical interests are in the area of surgical oncology, with special expertise in breast cancer and melanoma. Dr. Sabel is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Melanoma, Inflammatory Breast Cancer, Mastectomy, and Craniectomy. Dr. Sabel is board certified in Surgery.

Dr. Kathryn Welch is an Associate Professor of Obstetrics and Gynecology at the University of Michigan.She is a Michigan native who earned her undergraduate degree at Michigan State University. Dr. Welch then pursued her medical degree at Wayne State University School of Medicine and completed her residency training in Obstetrics and Gynecology at Wayne State University/Detroit Medical Center. Her practice encompasses general gynecology, with a focus on vulvar dermatoses, lower genital tract disease, and menopause.Outside of work, Dr. Welch enjoys spending time with her family. Dr. Welch is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Lichen Sclerosus, Lichen Planus, Vulvar Cancer, Intrauterine Device Insertion, and Hormone Replacement Therapy (HRT). Dr. Welch is board certified in Obstetrics & Gynecology.

Abby received her Bachelor's of Science in Nursing from Hope College. She went on to complete her Master's of Science in Nursing with a dual degree in Nurse-Midwifery and Family Nurse Practitioner in 2012.She enjoys taking care of women throughout the lifespan. She provides comprehensive gynecologic care in addition to vulvar diseases. She is happily married and has two sons. Interests outside of work include spending time with her family, exercising, and traveling. Ms. Brown is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her clinical expertise encompasses HER2 Negative Breast Cancer, BRCA Positive Breast Cancer, Menopause, and Intrauterine Device Insertion. Ms. Brown is board certified in Family Nurse Practitioner.

Kimberly Hoskins is a Nurse Practitioner practicing medicine in Brighton, Michigan. Ms. Hoskins is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses HER2 Negative Breast Cancer and BRCA Positive Breast Cancer. Ms. Hoskins is board certified in Adult Nurse Practitioner.

Dr. Jessica Hsu is a faculty member in the Section of Plastic Surgery at the University of Michigan and Director of Plastic Surgery at the Brighton Center for Specialty Care. Dr. Hsu received her medical and doctorate degrees from the University of Washington School of Medicine and Fred Hutchinson Cancer Research Center. She then completed integrated plastic surgery residency at the University of Michigan.Clinical SpecializationDr. Hsu’s specializes in general plastic surgery, particularly breast reconstruction. Dr. Hsu is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Breast Enlargement In Males, BRCA Positive Breast Cancer, HER2 Negative Breast Cancer, and Keloids. Dr. Hsu is board certified in Plastic Surgery.

Aimee Rolston is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Brighton, Michigan. Dr. Rolston is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Testicular Yolk Sac Tumor, Ovarian Carcinosarcoma, Ovarian Cancer, Hysterectomy, and Oophorectomy. Dr. Rolston is board certified in Obstetrics & Gynecology.

Dr. Turgeon received her medical degree from the University of Rochester in New York and her internal medicine residency at Strong Memorial Hospital at the University of Rochester. She also completed a fellowship in gastroenterology at the U-M Medical Center. Her special research interests include colon cancer, chemoprevention, drug metabolism and P450 enzymes. She performs diagnostic and therapeutic endoscopy. Dr. Turgeon is married and has two adult children. Dr. Turgeon is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Ulcerative Colitis, Hemorrhagic Proctocolitis, Crohn's Disease, Colonoscopy, and Endoscopy. Dr. Turgeon is board certified in Internal Medicine and Gastroenterology.

Dr. Xia is interested in improving of non-invasive diagnostic modalities of gastrointestinal diseases and cancers. His main research interest is in the development of microbiome and metabolomics based biomarkers to enhance endoscopic diagnosis of indeterminate biliary strictures and facilitate early diagnosis of pancreaticobiliary cancers. Dr. Xia is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Sclerosing Cholangitis, Cholangitis, Cholangiocarcinoma (Bile Duct Cancer), Childhood Pancreatitis, and Liver Transplant.

Jorge Machicado, MD, MPH, is a Clinical Assistant Professor in the Division of Gastroenterology and Hepatology. Dr. Machicado earned his medical degree from Universidad Peruana Cayetano Heredia in Lima, Peru. He received a Master of Public Health at Johns Hopkins Bloomberg School of Public Health. He completed his internal medicine residency at the University of Texas Health Science Center in Houston, gastroenterology fellowship at the University of Pittsburgh Medical Center, and advanced therapeutic endoscopy fellowship at the University of Colorado. He is board certified in Internal Medicine and Gastroenterology.Dr. Machicado has authored numerous peer-reviewed articles, abstracts, and book chapters. He serves as a member of the ASGE Standards of Practice Committee and a councillor of the AGA Institute Council Pancreatic Disorders Section. He is a frequently invited reviewer for Gastrointestinal Endoscopy, Clinical Gastroenterology & Hepatology, United European Gastroenterology Journal, among other journals. In his free time, he enjoys running, spending time with his kids, and exploring new restaurants. Dr. Rivero is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Childhood Pancreatitis, Hereditary Pancreatitis, Acute Pancreatitis, Bile Duct Stricture, and Pancreatectomy. Dr. Rivero is board certified in Gastroenterology.

I enjoy guitar playing and family tripsPeer-reviewed Publications 1) Ojima I, Borella CP, Wu X, Bounaud P-Y, Fumero C, Sturm M, Miller ML, Chakravarty S, Chen J, Huang Q, Pera P, Brooks TA, Baer MR, and Bernacki RJ. Design, synthesis and structure-activity relationships of novel taxane-based multidrug resistance reversal agents. Journal of Medicinal Chemistry. 2005 Mar; 48(6): 2218-2228.PMID:15771464.2) Sturm MB, Roday S, and Schramm VL. Circular DNA and DNA/RNA hybrid molecules as scaffolds for ricin inhibitor design. Journal of the American Chemical Society. 2007 May; 129(17): 5544-5550. PMID: 17417841.3) Roday S, Sturm MB, Blakaj D, and Schramm VL. Detection of an abasic site in RNA with stem-loop DNA beacons: application to an activity assay for Ricin Toxin A-Chain. Journal of Biochemical and Biophyscial Methods. 2008 Apr; 70(6): 945-953. PMID: 18276012.4) Sturm MB, and Schramm VL. Detecting ricin: sensitive luminescent assay for ricin A-chain ribosome depurination kinetics. Analytical Chemistry. 2009 Apr; 81(8): 2847-2853 PMID: 19364139.5) Sturm MB, Tyler PC, Evans GB, and Schramm VL. Transition state analogues rescue ribosomes from saporin-L1 ribosome inactivating protein. Biochemistry. 2009 Oct; 48(41): 9941-9948. PMID: 19764816.6) Ho MC, Sturm MB, Almo SC, and Schramm VL. Transition state analogues in structures of ricin and saporin ribosome-inactivating proteins. Proceedings of the National Academy of Sciences. 2009 Dec; 106(48): 20276-20281.PMID: 19920175.7) Sturm MB, Joshi BP, Lu S, Piraka C, Khondee S, Elmunzer BJ, Kwon RS, Beer DG, Appelman H, Turgeon DK, Wang TD, Targeted imaging of esophageal neoplasia with a fluorescently labeled peptide: First-in-human results. Science Translational Medicine. 2013, 5, 184. PMID: 23658246 8) Sturm MB, Piraka C, Elmunzer BJ, Kwon RS, Joshi BP, Appelman HD, Turgeon DK, Wang TD. In vivo molecular imaging of Barrett's esophagus with confocal laser endomicroscopy. Gastroenterology. 2013 Jul;145 (1):56-8, PMID: 236849439) Yaun H, Du Q, Sturm MB, Schramm VL. Soapwort Saporin L3 Expression in Yeast, Mutagenesis, and RNA Substrate Specificity. Biochemistry. 2015, 54, 29, 4565-74. PMID 26091305 10) Xiaowen Ma, Xiaoyu Kang, Lei He, Jiming Zhou, Juan Zhou, Matthew B. Sturm, David G. Beer, Rork Kuick, Derek J. Nancarrow, Henry D. Appelman, Zhijun Pang, Weina Li, Cun Zhang, Wei Zhang, Yingqi Zhang. Dr. Sturm is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Irritable Bowel Syndrome (IBS), Colitis, Colonic Malakoplakia, Endoscopy, and Tissue Biopsy.

Susan Egner is a Nurse Practitioner practicing medicine in Brighton, Michigan. She has been practicing medicine for over 18 years. Ms. Egner is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her clinical expertise encompasses BRCA Positive Breast Cancer and HER2 Negative Breast Cancer. Ms. Egner is board certified in Family Nurse Practitioner.

Lauren M. Perry, MD is an assistant professor in the Division of Surgical Oncology in the Department of Surgery at Michigan Medicine. Dr. Perry is trained in general surgery and specializes in treating patients with breast cancer. She practices at the Rogel Cancer Center, Brighton Center for Specialty Care, and East Ann Arbor Health Center.She earned her medical degree at the Emory University School of Medicine after receiving a merit scholarship. Following her medical education, she completed her general surgery training at the University of California Davis in Sacramento, California. During that time, she received a master's degree in clinical research under an NIH K30 award and was the recipient of a NIH T32 postdoctoral research fellowship in comparative oncology. She then completed her fellowship in breast surgical oncology at Memorial Sloan Kettering Cancer Center in New York City. Dr. Perry is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her clinical expertise encompasses Angiosarcoma, Inflammatory Breast Cancer, Li-Fraumeni Syndrome, and HER2 Negative Breast Cancer.

Anthony Scott is a Medical Genetics specialist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 10 years. Dr. Scott is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. He is also highly rated in 82 other conditions, according to our data. His clinical expertise encompasses HER2 Negative Breast Cancer, BRCA Positive Breast Cancer, Li-Fraumeni Syndrome, and Lacrimo-Auriculo-Dento-Digital Syndrome. Dr. Scott is board certified in Internal Medicine and Clinical Genetics & Genomics.

Adeyiza O. Momoh, M.D., James W. Crudup Professor serves as a faculty member in the Section of Plastic Surgery at Michigan Medicine.Dr. Momoh received his BS in Biology from Calvin College and his M.D. degree from Northwestern University School of Medicine. He completed his plastic surgery training at the Baylor College of Medicine, Michael E. DeBakey department of surgery. Following this, he spent a year of fellowship training in microsurgical breast reconstruction and aesthetic breast surgery at the Beth Israel Deaconess Medical Center of Harvard Medical School in Boston, Massachusetts.He is a member of the American Society of Plastic Surgeons, American College of Surgeons, American Society for Reconstructive Microsurgery, Plastic Surgery Research Council, Reed O. Dingman Society, Michigan Academy of Plastic Surgeons, and American Council of Academic Surgeons.Clinical Specialization: Dr. Momoh specializes in all forms of breast reconstruction and has a particular interest in microsurgical breast reconstruction, utilizing a variety of perforator flaps such as the DIEP, SIEA and SGAP flaps. Additional areas of clinical focus include breast augmentation, breast lifts and body procedures for mothers aimed at restoration of form following pregnancy. Dr. Momoh is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, Mastectomy, and Lymphadenectomy. Dr. Momoh is board certified in Plastic Surgery.

Paige L. Myers, MD, MPH, FACS, serves as a faculty member in the Section of Plastic Surgery at the University of Michigan School of Medicine and is the program director of the Integrated Plastic Surgery Residency. Dr. Myers obtained a Bachelor of Science Degree in Chemistry from Hobart and William Smith College. She then attended Upstate Medical University in Syracuse, NY for her medical degree. She completed a Plastic and Reconstructive Surgery Residency at the University of Rochester. She pursued a fellowship in reconstructive microsurgery at Memorial Sloan Kettering Cancer Center in New York, NY, to provide the most advanced reconstructive techniques to her patients.Clinical Specialization: Dr. Myers specializes in all forms of breast reconstruction, with a particular focus on microsurgical techniques. She has specialized training in using patients' own tissue from the abdomen, thighs, hips, or gluteal region. Additional clinical areas include lymphedema surgery and complex oncologic reconstruction, working closely with the University of Michigan Rogel Cancer Center to provide multidisciplinary, patient-centered care. Her research interests involve investigating the social determinants of health and current policies that affect the delivery of care for breast reconstruction and lymphedema patients. She is also passionate about mentorship and sponsorship in surgery, especially for women and underrepresented minorities. Dr. Myers is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Breast Enlargement In Males, Breast Cancer, Lymphedema, Mastectomy, and Lymphadenectomy. Dr. Myers is board certified in Plastic Surgery.

Jeffrey H. Kozlow, MD, serves as a Clinical Associate Professor in the Section of Plastic and Reconstructive Surgery at the University of Michigan School of Medicine. A native of Southeastern Michigan, Dr. Kozlow received his Bachelors of Arts in Psychology and Chemistry from Cornell University. He graduated from Johns Hopkins University School of Medicine for his M.D. degree. He underwent Plastic Surgery Residency training at the University of Michigan followed by an additional one-year fellowship in Microvascular Reconstructive Surgery at the University of Texas – MD Anderson Cancer Center. He has returned to the University of Michigan joining the faculty in 2011. Clinical Specialization: Dr. Kozlow is clinically focused on the reconstruction of oncologic and traumatic defects. His microsurgical training allows him to perform abdominally-based breast reconstruction including DIEP and muscle-sparing TRAM flaps. He partners with members of the University of Michigan Rogel Cancer Center to provide an integrated and multi-disciplinary reconstruction for complex defects including the extremities and pelvis. His goal is to perform reconstructions that optimize the function and form that can be lost following the surgical removal of tumors. He also treats patients with primary cutaneous malignancies including melanoma and other skin cancers. Dr. Kozlow is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Eccrine Porocarcinoma, Melanoma, Breast Cancer, Mastectomy, and Lymphadenectomy. Dr. Kozlow is board certified in Plastic Surgery.

Dr. Theodore Kung is a faculty member in the Section of Plastic Surgery at the University of Michigan. Dr. Kung received his medical degree from Case Western Reserve University. He then completed an integrated plastic surgery residency at the University of Michigan. In addition, he also pursued fellowship training at the University of Washington in Seattle to specialize in microsurgical reconstruction, breast reconstruction, and lymphedema surgery. Dr. Kung is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Phantom Limb Pain, BRCA Positive Breast Cancer, HER2 Negative Breast Cancer, Leg or Foot Amputation, and Lymphadenectomy. Dr. Kung is board certified in Plastic Surgery.

Kyle Wilson is a Radiologist and an Interventional Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Wilson is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. His clinical expertise encompasses HER2 Negative Breast Cancer, BRCA Positive Breast Cancer, Budd-Chiari Syndrome, and Cri-Du-Chat Syndrome. Dr. Wilson is board certified in Interventional Radiology & Diagnostic Radiology.